BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 18022337)

  • 1. Effect of zinc on cellular poly(ADP-ribosyl)ation capacity.
    Kunzmann A; Dedoussis G; Jajte J; Malavolta M; Mocchegiani E; Bürkle A
    Exp Gerontol; 2008 May; 43(5):409-14. PubMed ID: 18022337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly(ADP-ribosyl)ation, PARP, and aging.
    Beneke S; Bürkle A
    Sci Aging Knowledge Environ; 2004 Dec; 2004(49):re9. PubMed ID: 15590998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(ADP-ribosyl)ation: its role in inducible DNA amplification, and its correlation with the longevity of mammalian species.
    Bürkle A; Grube K; Küpper JH
    Exp Clin Immunogenet; 1992; 9(4):230-40. PubMed ID: 1307244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex vivo supplementation with nicotinic acid enhances cellular poly(ADP-ribosyl)ation and improves cell viability in human peripheral blood mononuclear cells.
    Weidele K; Kunzmann A; Schmitz M; Beneke S; Bürkle A
    Biochem Pharmacol; 2010 Oct; 80(7):1103-12. PubMed ID: 20599792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(ADP-ribosyl)ation and aging.
    Bürkle A; Beneke S; Muiras ML
    Exp Gerontol; 2004; 39(11-12):1599-601. PubMed ID: 15582275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(ADP-ribosyl)ation, genomic instability, and longevity.
    Bürkle A
    Ann N Y Acad Sci; 2000 Jun; 908():126-32. PubMed ID: 10911953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New polymorphisms in the human poly(ADP-ribose) polymerase-1 coding sequence: lack of association with longevity or with increased cellular poly(ADP-ribosyl)ation capacity.
    Cottet F; Blanché H; Verasdonck P; Le Gall I; Schächter F; Bürkle A; Muiras ML
    J Mol Med (Berl); 2000; 78(8):431-40. PubMed ID: 11097112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions.
    D'Amours D; Desnoyers S; D'Silva I; Poirier GG
    Biochem J; 1999 Sep; 342 ( Pt 2)(Pt 2):249-68. PubMed ID: 10455009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(ADP-ribosyl)ation: a posttranslational protein modification linked with genome protection and mammalian longevity.
    Bürkle A
    Biogerontology; 2000; 1(1):41-6. PubMed ID: 11707919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-selegiline potentiates the cellular poly(ADP-ribosyl)ation response to ionizing radiation.
    Brabeck C; Pfeiffer R; Leake A; Beneke S; Meyer R; Burkle A
    J Pharmacol Exp Ther; 2003 Sep; 306(3):973-9. PubMed ID: 12750436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haploinsufficiency of poly(ADP-ribose) polymerase-1-mediated poly(ADP-ribosyl)ation for centrosome duplication.
    Kanai M; Tong WM; Wang ZQ; Miwa M
    Biochem Biophys Res Commun; 2007 Aug; 359(3):426-30. PubMed ID: 17553458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oocyte numbers in the mouse increase after treatment with 5-aminoisoquinolinone: a potent inhibitor of poly(ADP-ribosyl)ation.
    Qian H; Xu J; Lalioti MD; Gulle K; Sakkas D
    Biol Reprod; 2010 May; 82(5):1000-7. PubMed ID: 20107208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(ADP-ribosyl)ation in carcinogenesis.
    Masutani M; Fujimori H
    Mol Aspects Med; 2013 Dec; 34(6):1202-16. PubMed ID: 23714734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of poly(ADP-ribose) glycohydrolase in the control of poly(ADP-ribose) metabolism.
    Davidovic L; Vodenicharov M; Affar EB; Poirier GG
    Exp Cell Res; 2001 Aug; 268(1):7-13. PubMed ID: 11461113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiology and pathophysiology of poly(ADP-ribosyl)ation.
    Bürkle A
    Bioessays; 2001 Sep; 23(9):795-806. PubMed ID: 11536292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient poly(ADP-ribosyl)ation of nuclear proteins and role of poly(ADP-ribose) polymerase in the early stages of apoptosis.
    Simbulan-Rosenthal CM; Rosenthal DS; Iyer S; Boulares AH; Smulson ME
    J Biol Chem; 1998 May; 273(22):13703-12. PubMed ID: 9593711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of telomerase activity by reduction of poly(ADP-ribosyl)ation of TERT and TEP1/TP1 expression in HeLa cells with knocked down poly(ADP-ribose) polymerase-1 (PARP-1) gene.
    Ghosh U; Das N; Bhattacharyya NP
    Mutat Res; 2007 Feb; 615(1-2):66-74. PubMed ID: 17141279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of poly(ADP-Ribose) polymerase 1 and poly(ADP-Ribosyl)ation in regulation of centrosome function.
    Kanai M; Tong WM; Sugihara E; Wang ZQ; Fukasawa K; Miwa M
    Mol Cell Biol; 2003 Apr; 23(7):2451-62. PubMed ID: 12640128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PARP1 is activated by membrane damage and is involved in membrane repair through poly(ADP-ribosyl)ation.
    Mashimo M; Kita M; Nobeyama A; Nomura A; Fujii T
    Genes Cells; 2022 Apr; 27(4):305-312. PubMed ID: 35124853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of poly(ADP-ribose) polymerase and distribution of poly(ADP-ribosyl)ation in glioblastoma and in a glioma multicellular tumour spheroid model.
    Wharton SB; McNelis U; Bell HS; Whittle IR
    Neuropathol Appl Neurobiol; 2000 Dec; 26(6):528-35. PubMed ID: 11123719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.